To study the effect of caregiver-focused interventions to support medication safety in older adults with chronic disease. DESIGN: Systematic review. SETTING: Studies published before January 31, 2017, searched using Ovid Medline, PubMed, EMBASE, Scopus, CINAHL, PsycINFO, and Google Scholar. PARTICIPANTS: Caregivers with or without a care recipient. MEASUREMENTS: Inclusion criteria: interventions focused on caregivers aiming to improve medication safety. Studies not focusing on older adults, not evaluating medication safety, failing to include caregivers, or without a comparison group were excluded. RESULTS: The initial search revealed 1,311 titles. Eight studies met inclusion criteria. The strategies used in randomized trials were a home-based medication review and adherence assessment by a clinical pharmacist (2 home visits 6-8 weeks apart, with pharmacist and physician meeting independently) that found no difference in nonelective hospital admissions (p=.8) but fewer medications (p=.03); a 19-minute educational DVD and an hour-long medication education and training that improved caregiver satisfaction (p<.04); a medication education and adherence intervention (2-3 home visits per care recipient and caregiver dyad over 8 weeks) that found no difference in knowledge, administration, or accessibility of medications (p=.29); and a collaborative case management program (16-month program of assessment, meeting, and monthly follow-up telephone calls) that reduced perceived caregiver burden (p=.03). Quasi-experimental trials included collaborative care transitional coaches, an outpatient collaborative care model, and education and training programs. Of these, educational interventions showed improvements in self-efficacy, confidence, and preparedness. The collaborative care intervention reduced rehospitalizations (p=.04) and improved quality-of-care outcomes. CONCLUSION: Although some interventions improved caregiver medication knowledge and self-efficacy, effects on clinical outcomes and healthcare use were insufficiently studied. Two studies implementing collaborative care models with medication management components showed potential for improvement in quality of clinical care and reductions in healthcare visits and warrant further study with respect to medication safety.
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Key words: caregivers; medication safety; medication adherence; older adults; aged; chronic disease; systematic review M edication safety means reducing harm by maximizing safe, prudent use of medications. 1, 2 The process of managing medications safely from the patient perspective is complex and has various components, including acquisition, storage, adherence, and monitoring of safety and efficacy parameters. Managing all components of medication use is challenging for older adults with chronic diseases. Older adults accounted for 13% of the U.S. population in the 2010 Census and consumed 34% of prescription and 30% of over-the-counter (OTC) medications. 3 Older adults are susceptible to adverse outcomes from medications because of multimorbidity and physiological changes with aging. [3] [4] [5] [6] Greater medical complexity increases problems with adherence, drug-drug interactions, and adverse effects. [3] [4] [5] [6] [7] [8] Older adults often have multiple chronic comorbidities, 4, 8 and multimorbidity often leads to use of multiple medications and polypharmacy. Polypharmacy is a term used to describe use of medications without an indication, use of medications that have more risks than benefits, or use of medications that have insufficient evidence supporting their use. 5 Polypharmacy has been correlated with geriatric syndromes including falls, adverse From the *Division of General Internal Medicine and Geriatrics; and † Ruth Lilly Medical Library, School of Medicine, Indiana University, Indianapolis, Indiana; drug effects, and poor adherence. 5 Prescribed medications are also further complicated by readily available OTC medications that increase risk of potentially harmful medication-related interactions and outcomes. 3 We define vulnerable elderly adults as those with chronic disease. They often face multiple barriers in adhering to their medications, 7 including multiple medications with multiple doses and dosing times, lack of medication adherence support, adverse side effects, drug interactions, and cost. Many vulnerable elderly adults, including those in the early stages of cognitive impairment, often look to caregivers to support adherence to medications. [8] [9] [10] The 30 billion hours in caring for elderly adults that informal caregivers spend every year illustrate the burden of caregiving in the United States. 11 An AARP study recently reported that nearly half of caregivers assist in medication management for older adults, irrespective of their cognitive status. 12 Another survey of 1,002 informal caregivers revealed that nearly 40% assisted in administration of medications, but 18% reported that they did not receive any training or instruction from a healthcare professional regarding medication administration and related precautions. 13 A qualitative study designed to highlight caregiver-reported challenges of medication management in caring for individuals with dementia described themes of medication management, communication, shared responsibility, and assessing harms and usefulness of medications. The authors concluded that emotional stress from these barriers is an unmet need and may adversely influence the caregiver's role in medication adherence and monitoring.
14 Because caregivers of vulnerable elderly adults experience a variety of medication-related challenges, our objective was to describe the design and effect of caregiver-focused interventions intended to support medication safety.
METHODS
We conducted a systematic evidence-based review of available literature to explore interventions for caregivers to improve medication safety in vulnerable elderly adults. We used key search terms to identify eligible studies published before January 31, 2017, in Ovid Medline, PubMed, EMBASE, Scopus, CINAHL, PsycINFO, and Google Scholar. Search terms included morbidity, chronic disease, dementia, cognitive disorder, medication adherence, patient safety, medication knowledge, elderly patients, polypharmacy, medication reconciliation, caregiver burden, caregivers, caregiver support, carer, aged, and vulnerable populations. Only English-language studies were included. Inclusion criteria were that participants were aged 65 and older and had a chronic condition and that the intervention focused on improving medication safety and was delivered at least in part to caregivers. Nonexperimental designs without comparison groups were excluded.
The lead author (KCW) compared the titles of studies identified in the initial search with the inclusion and exclusion criteria. After excluding those not meeting eligibility criteria, 2 authors (KCW, NLC) compared abstracts and manuscripts with the inclusion and exclusion criteria and removed those not meeting eligibility criteria. Disagreements on eligibility were resolved by discussion among all authors.
RESULTS
One thousand three hundred eleven studies met initial search criteria. Figure 1 illustrates the flow of screening and inclusion of identified studies. Because of the heterogeneity of the interventions and outcomes assessed, studies are presented based on study design. A brief description of each study follows. Table 1 summarizes the study populations, environments, interventions, and outcomes of the 4 randomized controlled trials (RCTs) and Table 2 of the 4 quasi-experimental trials.
Summary of Evidence from RCTs
Home-Based Pharmacist Consultation One study 15 described an intervention focused on adults aged 80 and older living in their own homes and prescribed 4 or more oral medicines per day along with at least 1 of living alone, record of confused mental state, impaired vision or hearing, prescribed medicines associated with medicationrelated morbidity, and prescribed more than 7 oral medicines. Participants randomized to the intervention received a one-time home visit from a clinical pharmacist who reviewed medications, provided medication-specific education, addressed barriers to managing medications, and made prescribing recommendations to the primary care provider. At 6 months, there was no difference between the intervention and usual care groups in number of nonelective hospital admissions, admission to nursing facilities, mortality, or quality of life, although intervention participants experienced a reduction in the number of medications than they had been at the beginning, whereas control group participants were not (p=.03). Differences in adverse events, measures of adherence, and other clinical outcomes such as level of disease state control were not reported.
Supporting Caregivers of Individuals with Individuals with Cancer
An intervention was developed for caregivers who were supporting individuals undergoing chemotherapy for breast, lung, or colon cancer. 16 The intervention was developed through collaboration between caregivers and the medical team based on care recipient and caregiver needs. The intervention was delivered through an audiovisual aid (DVD), reading materials, and a group visit that chemotherapy nurses facilitated. The content focused on medication education for chemotherapy, including expected adverse effects, caregiver expectations, and support. Intervention participants had greater caregiver satisfaction and a better experience serving as a caregiver (p<.04). The study did not report clinical outcomes such as chemotherapy adherence and tolerability.
Medication Management Training for Caregivers
An intervention was developed to train caregivers to address medication management challenges in communitydwelling elderly adults with memory problems. 17 Professionals from multiple disciplines met to develop content for the training program, which a nurse or social worker delivered in participant's homes in 2 to 3 home visits for each care recipient and caregiver dyad over an 8-week period. Each caregiver also received a follow-up telephone call from the interventionists every 2 weeks for the subsequent 8 weeks (total 16-week intervention). This intervention group was compared with a usual care group that received only reading materials about resources on medication safety. The study used 2 medication management evaluation tools. One was the Medication Management Instrument for Deficiencies in the Elderly (MedMaIDE) which surveys and observes caregivers with regard to medication management, specifically reporting skills in medication knowledge, administration, and access. The second was the Medication Deficiency Checklist (MDC), which interviews caregivers to assess medication administration errors and medication adherence. Although the intervention group perceived this training to be helpful and relevant in their role as caregivers, there were no significant differences between groups in MedMaIDE (p=.09) or MDC (p=.29) scores. The study did not report differences in measures of adherence, disease state control, or healthcare use.
Collaborative Case Management to Support Family Caregivers of Vulnerable Elderly Adults
A 16-week intervention, Health and Social Collaborative Case Management (HSC-CM), included a caregiver needs assessment, case management, medication management workshops, and coordination of care support by multiple disciplines, including nursing, social work, nutrition and physical therapy, to support family caregivers of frail elderly adults in the community. 18 Based on the needs assessment, caregivers are referred to workshops designed to address caregiving needs, such as nutritional management, stress management, and medication management, between the fifth and eleventh weeks of the program. Specifically, nurses provided medication management workshops. The authors reported greater improvement in perceived caregiving burden in the intervention group than the usual care geoup according to the Caregiver Burden Inventory (p=.03) and no difference in quality of life between the groups as reported on the Medical Outcomes Study Short-Form Health Survey (p>.04). No clinical outcomes related to differences in medication adherence, disease state control, or healthcare use were reported.
Summary of Evidence of Quasi-Experimental Trials

Transitional Collaborative Care
In a transitional intervention initiated during a hospital stay, a geriatric nurse practitioner (NP) provided medication selfmanagement tools, a personal health record with education on active health problems, and collaboration of care within primary and specialty care. 19 When patients transitioned out of the hospital, the NP followed up with telephone calls and visits to a skilled nursing facility or the home to continue education regarding ongoing health concerns and to perform a medication history with reconciliation. The intervention was conducted in individuals discharged from the study hospital, and comparators were historical controls from administrative data. The intervention targeted the care recipient-caregiver dyad and included telephone calls and face-to-face visits to support transition to home after a skilled nursing facility stay. The intervention provided education and supported maintenance of a personal health record, medication self-management, coordination of care with providers, and monitoring of disease symptoms for acute decompensation. The intervention led to fewer nonelective rehospitalizations at 30, 90, and 180 days than in the administrative control group and fewer emergency department visits at 90 but not 30 or 180 days. Outcomes related to medication adherence were not reported, although the intervention resulted in increases in medication knowledge and self-management from baseline, but no comparison with controls was available given the design of the study.
Collaborative Care Model for Caregivers of Individuals with Dementia 20
An outpatient collaborative care model targeting individuals with cognitive impairment supported by interdisciplinary team members was developed. The team conducted a comprehensive assessment of caregiver knowledge of cognitive 
Teaching Hospitalized Individuals and Their Caregivers About Medication Management
An intervention was developed that includes education of the care recipient-caregiver dyad on medication management, symptom management, and availability of community healthcare resources before discharge from a hospital stay. 21 A trained nurse delivered the intervention, which occurred at a single point in time (up to 1.5 hours) before discharge. Caregiver self-efficacy defined according to modified Lorig Self-Efficacy score improved (baseline score 783.86, immediate posttraining score 903.64, 1-week posttraining score 867.85, 4-week posttraining score 877.02). Similar increases were seen in measures of caregiver preparedness, but no comparisons of statistical significance were provided. No objective measures of medication adherence, disease state control, or healthcare use were reported, although participants reported satisfaction with the intervention.
Teaching Caregivers and Care Recipients About Discharge Medications
Three approaches to teaching caregivers and care recipients about discharge medications in an inpatient rehabilitation setting were tested: 22 a standard medication information sheet with nurse review, medication information delivered in a geragogy format, and medication information delivered in a geragogy format with a follow-up session to reinforce education and answer questions. No differences in medication knowledge were reported between teaching methods, although all groups improved from baseline. Confidence in medication administration improved in caregivers (p<.001), but no difference in method was reported. The authors did not report objective measures of medication adherence, disease state control, or rehospitalization.
DISCUSSION
The findings from this systematic evidence-based review highlight a paucity of data describing caregiver-focused interventions that improve medication safety and related clinical outcomes. Only 3 of the 8 selected studies reported clinical outcomes such as fewer medicines, change in hospitalization, change in adverse outcomes, difference in use of inappropriate medications, or medication adherence. 15, 19, 20 Multicomponent collaborative interventions that included medication management improved rehospitalization rates, medication appropriateness, disease state control, and acute care use in low-income elderly adults. 19, 20 The variation in design, setting, population, intervention, and outcome measures of the included studies are notable. Interventions were presumably developed from different stakeholder priorities, needs assessments, and intended applications. It was unclear in most articles whether the logic model for the tested intervention was implemented to improve a clinical outcome, care recipientreported outcome, or caregiver-reported outcome. A variability in setting could lead to an unknown effect on outcomes. As such, the quality of the evidence in generating a positive clinical effect was deemed to be weak. Most interventions provided education and enhanced communication to the care recipient and caregiver, and interventions showing improved clinical outcomes enhanced communication among the dyad and the healthcare team members.
A systematic approach to review and reconciliation of medications was an integral part of several studies in the review. 15, 18, 19 A clinical pharmacist, 15 nurse, 18 or nurse practitioner 19 conducted this component of the interventions, but the heterogeneity of the interventions precludes comparison of results based on the background of the interventionist. Two RCTs 16, 17 and two quasi-experimental trials 21, 22 highlighted training and education as caregiver interventions; they emphasized a need for such programs to occur in face-to-face formats in a facility or at home. In these studies, nursing staff were delivered education and training, but in another study, 17 a nurse or social worker delivered training. Again, no comparison between disciplines was reported, but the study indicates a role for a social worker to be engaged in medication safety. 17 Although we believe that interventions improving caregiver knowledge are valuable, these activities are difficult to justify in current payment models without associated improvement in quality of care or clinical outcome. It is important to select appropriate clinical and quality measures for various populations and settings. For chronic care management, such clinical outcomes could include medication adherence, achievement of clinical targets, and healthcare use due to medication-related adverse events. In contrast, for individuals receiving palliative care, reducing harm, improving quality of life, and increasing comfort are appropriate clinical outcomes. Outcomes included in caregiver-based research should serve to measure the effect of an intervention and correlate with a meaningful clinical outcome. Accuracy of medication administration and selfefficacy measures in managing chronic disease are ideal caregiver-reported outcomes that may improve medication management and safety, but optimal measures for such outcomes have yet to be universally accepted.
Caregivers observe care recipients' symptoms and signs closely, and this care recipient-specific knowledge can be important to consider in medication management. 23 Caregivers may also influence medication management through their own sources of bias. 23 . A large study showed that medication adherence was 2.95 times as great with caregivers who reside with a care recipient and have lower stress levels than with caregivers who do not reside with the care recipient and have higher level of stress. 24 Caregivers might have different needs based on the characteristics and clinical needs of the care recipient they are supporting, such as dementia, cancer, and other chronic medical conditions. Similarly, the caregiver's personality, relationship with the care recipient, and healthcare literacy may influence their needs. A common thread is a need for better communication and skill sets specific to medication administration and monitoring. In one study, caregivers referred themselves to the study after seeing notices about the study, this suggests that only highly motivated caregivers could be self-recruited for the trial, and this may not reflect general caregiver characteristics, including demographic characteristics; this is another example of limitation in caregiver research. 17 Although some vulnerable elderly adults may not be able to embrace technological assistance to aid in medication management, caregivers could be identified as alternative users of related technology. Studies of web-based interventions in support of medication safety practices are promising 26, 27 but failed to meet inclusion criteria for this review. Given the potential value of technology, further work will be needed to understand its role in supporting caregivers in medication safety and its effect on clinical outcomes.
Limitations of this review include small, mostly singlesite samples. Most studies investigated caregiver awareness, satisfaction, self-efficacy, and knowledge rather than clinical outcomes. 16, 22 Needs of vulnerable elderly adults with cognitive impairment may be different from needs of those without cognitive impairment, and most studies did not report findings stratified according to cognitive ability. Caregivers and care recipient-caregiver dyads who are highly motivated to improve healthcare practices are the likely participants in this research, which may not be generalizable to all caregivers. 17 Given heterogeneous outcomes of the included studies, a quantitative meta-analysis was not feasible. Because an underdeveloped assessment of clinical effect limited the intervention and limit the field in general, it is premature to determine whether the value justifies the cost. Additional work to understand clinical effect is warranted for this and other interventions while considerations of cost are pursued in interventions showing meaningful clinical effect.
CONCLUSION
This review illustrates that a variety of approaches executed by various members of the healthcare team have been attempted to improve medication management for vulnerable older adults. Although interventions designed to improve medication knowledge and self-efficacy were successful, these interventions had no effect on clinical outcomes or healthcare use, or the effect was insufficiently studied. In 2 studies, collaborative care models showed potential for improvements in quality of clinical care and reductions in healthcare visits. Interventions that reduce caregiver burden and increase satisfaction and confidence with medication management are valuable in quality-based care organization, but additional support from evidence establishing improvements in clinical outcomes will be critical for implementation. Interventions that showed reductions in number of medications and rehospitalizations and better quality of care of chronic diseases are potential strategies identified in this review that warrant further study. Understanding the essential components of caregiver-based interventions, including content, delivery, dose, and duration, are important next steps to expand and optimize clinical, quality, and financial outcomes.
